Literature DB >> 3969814

Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.

S Lundin, P Melin, H Vilhardt.   

Abstract

A sensitive and specific radioimmunoassay for 1-deamino-8-D-arginine vasopressin (DDAVP) was developed. Plasma concentrations of DDAVP after intragastric administration were determined in non-fasted rats and a dose-related increase in plasma levels was obtained. The immunoidentity of plasma DDAVP and standard was established by high performance liquid chromatography (HPLC). Correlation of biological and immunological responses of DDAVP was assessed using the antidiuretic effect in the Brattleboro (diabetes insipidus) rat.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3969814     DOI： 10.1530/acta.0.1080179

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


  5 in total

1.  Indirect-response modeling of desmopressin at different levels of hydration.

Authors:  T Callréus; J Odeberg; S Lundin; P Höglund
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

2.  Clinical study shows improved absorption of desmopressin with novel formulation.

Authors:  Nelly Fransén; Susanne Bredenberg; Erik Björk
Journal:  Pharm Res       Date:  2009-03-19       Impact factor: 4.200

3.  Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in man.

Authors:  L d'Agay-Abensour; A Fjellestad-Paulsen; P Höglund; Y Ngô; O Paulsen; J C Rambaud
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Absorption of an oxytocin antagonist (antocin) and a vasopressin analogue (dDAVP) through a standardized skin erosion in volunteers.

Authors:  S Lundin; P Svedman; P Höglund; K Jönsson; A Broeders; P Melin
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

5.  Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients.

Authors:  Henrik Agersø; Lotte Seiding Larsen; Anders Riis; Ulf Lövgren; Mats O Karlsson; Thomas Senderovitz
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.